In neurons, Glycogen Synthase Kinase‐3β (GSK‐3β) has been shown to regulate various
critical processes underlying structural and functional synaptic plasticity. Mouse models with …

Psychotropic drugs acting on monoamine neurotransmission are major pharmacological
treatments for neuropsychiatric conditions such as schizophrenia, depression, bipolar …

Drugs that act on dopamine neurotransmission are important tools for the management of
multiple neuropsychiatric disorders. Classically, dopamine receptors have been shown to …

MicroRNAs (miRNAs) are a large family of small non-coding RNAs which negatively control
gene expression at both the mRNA and protein levels. The number of miRNAs identified is …

Objective: The authors used a custom array of 1,536 single-nucleotide polymorphisms
(SNPs) to interrogate 94 functionally relevant candidate genes for schizophrenia and identify …

Schizophrenia is a prevalent complex trait disorder manifested by severe neurocognitive
dysfunctions and lifelong disability. During the past few years several studies have provided …

Schizophrenia is a complex disorder, where family, twin and adoption studies have been
demonstrating a high heritability of the disease and that this disease is not simply defined by …

Abstract The neuregulin 1 (NRG1) receptor, ErbB4, has been identified as a potential risk
gene for schizophrenia. HER4/ErbB4 is a receptor tyrosine kinase whose transcript …

The mammalian target of rapamycin (mTOR) is an ubiquitously expressed serine-threonine
kinase, which senses and integrates several intracellular and environmental cues to …

Over the last decade, finding a reliable biomarker for the early detection of schizophrenia
(Scz) has been a topic of interest. The main goal of the current review is to provide a …